quinoline has been researched along with Central Nervous System Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Béni, Z; Bobok, A; Domány, G; Gál, K; Galambos, J; Greiner, I; Keserű, GM; Kolok, S; Kóti, J; Mikó-Bakk, ML; Nógrádi, K; Sághy, K; Szakács, Z; Szombathelyi, Z; Vastag, M; Wágner, G | 1 |
1 other study(ies) available for quinoline and Central Nervous System Disease
Article | Year |
---|---|
4-Aryl-3-arylsulfonyl-quinolines as negative allosteric modulators of metabotropic GluR5 receptors: From HTS hit to development candidate.
Topics: Allosteric Regulation; Animals; Central Nervous System Diseases; High-Throughput Screening Assays; Humans; Protein Binding; Quinolines; Rats; Receptor, Metabotropic Glutamate 5; Structure-Activity Relationship | 2016 |